Foscarnet Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00529 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 63 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 2 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | diabetic nephropathy | KG + DL |
| 5 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 6 | gout | KG + DL |
| 7 | brachydactyly-syndactyly syndrome | KG + DL |
| 8 | sclerosing cholangitis | KG + DL |
| 9 | methemoglobinemia, alpha type | KG + DL |
| 10 | congestive heart failure | KG + DL |
| 11 | methemoglobinemia | KG + DL |
| 12 | methemoglobin reductase deficiency | KG + DL |
| 13 | HIV infectious disease | KG + DL |
| 14 | paratenonitis | KG + DL |
| 15 | calcific tendinitis | KG + DL |
| 16 | acute pulmonary heart disease | KG + DL |
| 17 | myositis | KG + DL |
| 18 | chronic kidney disease | KG + DL |
| 19 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 20 | osteoarthritis susceptibility | KG + DL |
| 21 | osteoarthritis | KG + DL |
| 22 | bronchitis | KG + DL |
| 23 | IgG4-related pachymeningitis | KG + DL |
| 24 | end stage renal failure | KG + DL |
| 25 | obsolete hyperuricemia (disease) | KG + DL |
| 26 | simian immunodeficiency virus infection | KG + DL |
| 27 | feline acquired immunodeficiency syndrome | KG + DL |
| 28 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 29 | methemoglobinemia due to deficiency of methemoglobin reductase | KG + DL |
| 30 | chronic renal failure syndrome | KG + DL |
| 31 | hypoalphalipoproteinemia | KG + DL |
| 32 | IgG4-related mediastinitis | KG + DL |
| 33 | eosinophilic angiocentric fibrosis | KG + DL |
| 34 | IgG4-related mesenteritis | KG + DL |
| 35 | IgG4-related aortitis | KG + DL |
| 36 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 37 | brachyolmia | KG + DL |
| 38 | obsolete familial combined hyperlipidemia | KG + DL |
| 39 | Lesch-Nyhan syndrome | KG + DL |
| 40 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 41 | pseudoachondroplasia | KG + DL |
| 42 | IgG4-related hepatopathy | KG + DL |
| 43 | conjunctivitis | KG + DL |
| 44 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 45 | pneumonia | KG + DL |
| 46 | myosclerosis | KG + DL |
| 47 | arthropathy | KG + DL |
| 48 | myositis fibrosa | KG + DL |
| 49 | idiopathic granulomatous myositis | KG + DL |
| 50 | familial porphyria cutanea tarda | KG + DL |
(Showing top 50 of 63 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.